ANTABIO
Entity

  • ANTABIO

    Created in 2009
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups

  • Social networks

    635 529 5,718

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Rue Pierre et Marie Curie, 31670 Labège, France

    Labège

    France

  • Employees

    Scale: 11-50

    Estimated: 20

  • SIREN

    517511291

  • Engaged corporates

    21
    8 13

  • Added in Motherbase

    3 years, 11 months ago
Description
  • Value proposition

    Developing Tomorrow's Antibacterials

    Antabio is a privately-held clinical-stage biopharmaceutical company developing novel and highly differentiated antibacterial treatments for drug-resistant infections due to CDC and WHO critical priority pathogens. Please visit www.antabio.com and follow us on Twitter @antabio

    Antibacterial drug discovery, Drug development, and Antibiotic Adjuvant

  • Original language

    Developing Tomorrow's Antibacterials

    Antabio is a privately-held clinical-stage biopharmaceutical company developing novel and highly differentiated antibacterial treatments for drug-resistant infections due to CDC and WHO critical priority pathogens. Please visit www.antabio.com and follow us on Twitter @antabio

  • Antabio

    Antabio is a private biopharmaceutical company developing antibacterial resistance-breakers in areas of highest medical need.

    • https://antabio.com/
Corporate interactions BETA
Corporate TypeTweets Articles
bioMérieux
bioMérieux
Biotechnology, Biotechnology Research
bioMérieux
Biotechnology, Biotechnology Research 		Capitalistic
Partnership
Not event

10 Jan 2022

17 Oct 2023



Similar entities
Last news
Show all articles
Social network dynamics